Axa’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.95M | Sell |
280,152
-273,530
| -49% | -$1.9M | 0.01% | 775 |
|
2025
Q1 | $4.7M | Sell |
553,682
-277
| -0.1% | -$2.35K | 0.02% | 560 |
|
2024
Q4 | $7.76M | Sell |
553,959
-440
| -0.1% | -$6.16K | 0.02% | 432 |
|
2024
Q3 | $12.5M | Buy |
554,399
+79
| +0% | +$1.79K | 0.04% | 360 |
|
2024
Q2 | $11.2M | Buy |
554,320
+157
| +0% | +$3.18K | 0.03% | 376 |
|
2024
Q1 | $13.8M | Buy |
554,163
+77
| +0% | +$1.92K | 0.04% | 341 |
|
2023
Q4 | $10M | Sell |
554,086
-20,981
| -4% | -$379K | 0.03% | 392 |
|
2023
Q3 | $11.6M | Buy |
575,067
+21,435
| +4% | +$431K | 0.04% | 365 |
|
2023
Q2 | $14.1M | Buy |
553,632
+93,507
| +20% | +$2.39M | 0.05% | 345 |
|
2023
Q1 | $9.79M | Buy |
460,125
+79,570
| +21% | +$1.69M | 0.03% | 418 |
|
2022
Q4 | $11.3M | Sell |
380,555
-30,085
| -7% | -$891K | 0.04% | 416 |
|
2022
Q3 | $9.55M | Sell |
410,640
-52,387
| -11% | -$1.22M | 0.04% | 440 |
|
2022
Q2 | $7.77M | Buy |
463,027
+317,773
| +219% | +$5.33M | 0.03% | 478 |
|
2022
Q1 | $6.37M | Buy |
145,254
+2
| +0% | +$88 | 0.02% | 582 |
|
2021
Q4 | $8.84M | Sell |
145,252
-53,421
| -27% | -$3.25M | 0.02% | 531 |
|
2021
Q3 | $8.26M | Buy |
198,673
+1,163
| +0.6% | +$48.4K | 0.02% | 547 |
|
2021
Q2 | $6M | Sell |
197,510
-289
| -0.1% | -$8.77K | 0.02% | 657 |
|
2021
Q1 | $5.91M | Buy |
197,799
+52,802
| +36% | +$1.58M | 0.02% | 666 |
|
2020
Q4 | $2.6M | Buy |
+144,997
| New | +$2.6M | 0.01% | 810 |
|